In Alzheimer's, the disease-related protein Tau is hyperphosphorylated and aggregates into neurofibrillary tangles (NFT). The cis isomer of the phosphorylated Thr231-Pro232 has been proposed as a precursor of aggregation ('Cistauosis'), but this aggregation scheme is not yet completely accepted. Here, we synthesized peptides comprising a phosphorylated region including Thr231-Pro232 and an aggregation-core region R1 to investigate isomer-specific-aggregation of Tau. The phosphorylated peptide formed amyloid-like aggregation. This aggregation was observed even in the presence of the catalytic domain of the peptidyl-prolyl-isomerase Pin1, which preferentially converts the cis isomer to the trans isomer, but decreased drastically in the presence of the WW domain of Pin1 selectively binding to the trans isomer. These results indicate that the trans isomer is aggregation-prone and that the WW domain of Pin1 effectively inhibits its aggregation.
In Alzheimer's, the disease-related protein Tau is hyperphosphorylated and aggregates into neurofibrillary tangles (NFT). The cis isomer of the phosphorylated Thr231-Pro232 has been proposed as a precursor of aggregation ('Cistauosis'), but this aggregation scheme is not yet completely accepted. Here, we synthesized peptides comprising a phosphorylated region including Thr231-Pro232 and an aggregation-core region R1 to investigate isomer-specific-aggregation of Tau. The phosphorylated peptide formed amyloid-like aggregation. This aggregation was observed even in the presence of the catalytic domain of the peptidyl-prolyl-isomerase Pin1, which preferentially converts the cis isomer to the trans isomer, but decreased drastically in the presence of the WW domain of Pin1 selectively binding to the trans isomer. These results indicate that the trans isomer is aggregation-prone and that the WW domain of Pin1 effectively inhibits its aggregation.
Keywords: Alzheimer's disease; Pin1; Tau Alzheimer's disease, a neuropathological disease, is the most common form of dementia. It is believed to be triggered by the accumulation of amyloid-b peptide and then promoted by hyperphosphorylation of microtubule-associated protein Tau [1, 2] . Hyperphosphorylation of Tau abolishes its ability for binding to tubulin subunits and stabilizing the assembled microtubule. When hyperphosphorylated, Tau is released from tubulin and aggregates into neurofibrillary tangles (NFT); thus, causing cell death by apoptosis [3] [4] [5] [6] [7] [8] [9] . According to Lu and his colleagues, cis isomer of the pThr231-Pro232 of Tau is much more aggregation-prone than the trans one, which is proposed as 'cistauosis' [10] [11] [12] . This hypothesis is supported by some experimental results in which NFT was colocalized with Pin1 [13, 14] and NFT was more accumulated in transgenic mouse without a peptidyl-prolyl isomerase (PPIase) Pin1 [15] . Pin1 specifically isomerizes Abbreviations NFT, neurofibrillary tangle; PPIase, peptidyl-prolyl isomerase; pSer/pThr-Pro, phosphorylated serine or threonine preceding a proline; SD, standard deviation. the phosphorylated serine or threonine preceding a proline (pSer/pThr-Pro) motif, and it is expected to convert the cis isomer of Tau to the trans one; thus, preventing the accumulation of NFT [16] . Direct evidence supporting 'cistauosis', however, is limited to in vivo experiments with isomer-specific antibody [11, 17] . On the other hand, most of in vitro studies have been limited to the interactions between Pin1 and short Tau peptides including pThr231-Pro232 region because it is difficult to directly investigate the relationship between aggregation and isomerization of Tau peptide. Nuclear magnetic resonance (NMR) studies showed that the peptides had extremely low cis-isomeric ratios [11, 18] and Pin1 did not isomerize the pThr231-Pro232 bond [19] ; thus, contradicting 'cistauosis'. Concerning in vitro studies on aggregation, the short peptides consisting of only the third microtubule-binding repeat (R3) of Tau as well as the long peptides K18 and K19 consisting of, respectively, only the four and three repeats, provided various structural insights into NFT [20] [21] [22] [23] [24] [25] [26] [27] . However, the 'cistauosis' remained unsolved because of the lack of an in-vitro model system that simultaneously examines isomerization of the pThr231-Pro232 bond during monitoring aggregation of Tau.
Here, we constructed three types of short peptides to investigate the correlation between the isomeric state of the pThr231-Pro232 bond and the aggregation of Tau. In addition, these peptides were available to investigate the inhibitory effect of Pin1 on the aggregation of Tau. NMR measurements showed that 97.9% of the pThr231-Pro232 bonds have the trans configuration, and Pin1 did not catalyze isomerization of the bond, which confirmed the previous reports. Amyloid-like aggregation of the peptides was observed using dynamic light scattering (DLS), thioflavine S (ThS) fluorescence, and electron microscopy (EM). Furthermore, the isolated WW domain of Pin1 selectively binding to the trans isomer, drastically decreased the aggregation, suggesting that the trans isomer was prone to aggregation. These results imply the existence of an aggregation mechanism different from 'cistauosis'.
Materials and methods

Materials
The cloned gene of wild-type (WT) human Pin1 was a generous gift from Professor N. Takahashi, Tokyo University of Agriculture and Technology. Restriction endonucleases, T4-DNA ligase, and JM109 competent cells were all purchased from Takara Bio, Inc. (Tokyo, Japan).
Peptide synthesis
We designed three peptides, two 45mer-peptides (DR1 and DR1-p231) for DLS, ThS fluorescence and EM measurements, and a 25mer-peptide (p231-6H3G) for NMR measurements (Fig. 1A) . The three peptides were chemically synthesized, using a solid-phase peptide synthesizer (Sigma Aldrich Japan K.K., Tokyo, Japan). Cdc25C phosphopeptide, purchased from Funakoshi (Tokyo, Japan) was used as a control in the NMR measurements [18, 28] .
Expression plasmid and site-directed mutagenesis of Pin1
The gene of WT Pin1 was amplified by polymerase chain reaction using 2 specific primers with either NdeI or BamHI restriction site. After subjecting the fragment to an NdeI/ BamHI double digestion, it was cloned into the expression vector pET28a (Novagen, EMD Biosciences, Inc., San Diego, CA, USA). The expression plasmid containing mutations of G44E/G45N/K46L/N47Y/G48F was then constructed using the QuikChange site-directed mutagenesis Fig. 1 . Schematic structures of Tau peptides and Pin1. (A) Two 45mer-peptides, DR1 and DR1-p231, consist of the second prolinerich domain (Arg230 to Leu243; PRD2) and the microtubule-binding repeat 1 (Gln244 to Lys274; R1). A 25mer-peptide, p231-6H3G, consists of highly soluble six His-tag, flexible triple Gly-linker, and the second proline-rich domain (Glu222 to Ser237; PRD2). A dansyl group was attached to the N-terminal amide group of the first arginine residue for DR1 and DR1-p231, while phosphorylated (P) Thr231 was attached instead of Thr231 in the synthesis of p231-6H3G and DR1-p231. (B) Pin1, which consists of the WW domain and PPIase domain. The WW domain selectively binds to the trans pSer/pThr-Pro bond, while PPIase domain can binds to both isomers of the pSer/pThr-Pro bond but prefers to cis isomer and catalyzes the interconversion between cis and trans ones.
kit (Stratagene Co., La Jolla, CA, USA) with specific mutagenic primers. These mutations allowed us to easily prepare the N-terminal WW domain (1-49) and the C-terminal PPIase domain (50-163) by TEV protease digestion after expression and purification of the full-length Pin1 (Fig. 1B) . The DNA sequences of all the expression plasmids were confirmed by nucleotide sequencing.
Overexpression and purification of Pin1
Expression plasmids, WT and mutant, were transformed into competent Escherichia coli C41(DE3) cells [29] . Two milliliters of overnight preculture of the cells supplemented with 50 lgÁmL À1 kanamycin was inoculated into 1 l of 29
YT medium supplemented with 50 lgÁmL À1 kanamycin, and this culture was grown to the log phase. Protein overproduction was initiated by adding 1 mM isopropyl b-D-thiogalactopyranoside. The culture was grown for an additional 4 h, and the cells were collected by centrifugation. The cell pellet was once frozen at À30°C, then thawed slowly at room temperature, and suspended in 50 mM Tris-HCl buffer (pH 8.0) containing 500 mM NaCl, 5% glycerol, 20 mM imidazole, 1% Tween 20, and 1 mM DTT (Buffer A). The cells were then lysed by sonication using a Branson sonicator. After centrifugation, the supernatant was subjected to nickel-chelating chromatography, HisTrap FF crude (5 mL) (GE Healthcare, Chicago, IL, USA) equilibrated with Buffer A, and the protein was eluted with 500 mM imidazole. The eluate was diluted twice with 50 mM Tris-HCl buffer (pH 8.0) containing 1 mM DTT, and then passed through a cation exchange column, SP Sepharose FF (GE Healthcare) equilibrated with the same buffer. The column was eluted with a linear gradient of NaCl to a final concentration of 1 M. The fractions containing the protein were then passed through a Superdex 75 column (GE Healthcare) equilibrated with 50 mM Tris-HCl buffer (pH 8.0) containing 50 mM NaCl and 1 mM TCEP. After analysis by SDS/PAGE, the purified protein solution was stored at 4°C. The N-terminal WW domain and Cterminal PPIase domain were obtained by TEV-proteasedigestion at 20°C for 50 h. The two domains were individually purified with the Superdex 75 column after cleavage. The concentration of Pin1 and its separated domains was determined by UV absorption at 280 nm using molar extinction coefficients estimated with the method developed by Pace et al. [30] .
Measurements of aggregation
Aggregating process of the peptides was measured by DLS [26, 31] . It was performed on a Zetasizer lV instrument (Malvern Instruments Ltd., Malvern, UK To assay fibrous property of the aggregation of DR1-p231 in the absence of Pin1, the ThS (Sigma-Aldrich) fluorescence was measured with 440 nm excitation by a JASCO FP-6500 spectrofluorometer [25, [32] [33] [34] . The ThS was added to the sample solution at a final concentration of 200 lM just before its measurement. Before the present experiments, we confirmed that ThS fluorescence was not affected by the dansyl group attached at the N terminal of DR1-p231 (data not shown).
At the end of the aggregation experiment, the shape of the aggregation was assayed by EM and fluorescent microscopy. In EM measurements, a drop of the sample solution was applied to carbon-coated copper grid, blotted, stained with 1% uranyl acetate and visualized under a Hitachi H-7600 electron microscope operated at 100 keV and at a nominal magnification of 40 000. Films were digitized with a Zeiss Z/I Imaging PhotoScan 2000 (Oberkochen, Germany) in 7 lm steps. On the other hand, in fluorescent microscopy, fluorescence of a dansyl group attached at the N terminal of DR1-p231 was observed by a Nikon inverted microscope TE2000U with a fluorescent filter cube of B (Blue excitation, Yellow-Green emission). Images were acquired, using a Plan Apo 100X/1.40 Oil DIC H objective lens and a Hamamatsu ORCA2 digital camera (C4742-98). A software AQUACOSMOS 2.5 was used for data acquisition and analysis.
A dansyl group was attached at the N terminals of DR1 and DR1-p231 to identify their aggregation using its fluorescence. The fluorescence change of the group was very small (about 1%) during aggregation (Fig. S1 ), suggesting the environment around the group hardly changed during the aggregation. Therefore, the dansyl group did not affect aggregation behavior of the peptides in the present experiments. H T 2 experiment of p231-6H3G peptide were 10, 50, 100, 150, 200, 250, 375, and 500 ms. Data were analyzed using Bruker Topspin. Cdc25C phosphopeptide was applied as a control for isomerization. Other experimental conditions and analytical methodology were used as described elsewhere [18, 28, 35, 36] .
Measurements of isomerization
Results and Discussions
A 45mer-peptide mimics aggregation-behavior of Tau
We constructed a tau peptide (DR1-p231) consisting of the second proline-rich domain (PRD2), including the phosphorylated Thr231-Pro232 bond and the first microtubule-binding repeat R1 (Fig. 1A ) in order to elucidate the relationship between the cis/trans isomeric state at the bond and the aggregation propensity of the peptide. Although the isolated R1 region (R1 peptide) was reported to be less aggregation-prone [24, 25, 37] , our peptide formed large aggregation with 863.9 AE 46.1 nm of hydrodynamic diameter after 11 days' incubation ( Fig. 2A) . Additional 15 amino acid prior to R1 possibly increased aggregation tendency. NMR showed that PRD2 has the intrinsic propensity to form a helical conformation and the phosphorylation of Thr231 increases the helical propensity by a salt bridge between its phosphate group and the side chain of Arg230 [38] . Such conformational property of PRD2 might decrease the entropy of the intrinsic disordered R1, and then the self-association of the peptide might be promoted by the enthalpy-entropy compensation. The ThS fluorescence emission spectrum (excitation = 440 nm) of the solution including this aggregation showed a single broad peak at 549 nm (Fig. 2B) . Referring to the ThS fluorescence spectrum of Tau fragment K19, the peak wavelength shifted from 572 to 534 nm after forming NFT [34] , suggesting that our solution partially contained amyloid-like fiber. We further incubated this amyloid-like aggregation for 1 month and obtained its image by EM (Fig. 2C) . In the images, fibrous aggregation was detected among amorphous ones; the longest filament was more than 4 lm long and its average width was about 200 nm (Fig. 2C) . Larger precipitate was also observed by fluorescent microscopy where fluorescence of a dansyl group attached at the N terminal of the peptide was observed (Fig. 2D) , indicating the fibrous aggregation was composed of DR1-p231. We also observed fluorescence of the dansyl group during the aggregation, and confirmed that the dansyl group hardly affected the fibrously aggregating behavior of the peptide (see Materials and methods, and Fig. S1 ).
On the other hand, we also synthesized the dephosphorylated peptide DR1 (Fig. 1A ) whose fibrously aggregating behavior was characterized as seen in Fig. S2 , and compared propagation of its aggregation with that of DR1-p231; while Z-average-size of the DR1 aggregation fluctuated around 200 nm during 100 h (Fig. 3A) , Z-average-size of the DR1-p231 aggregation increased from 200 nm to 600 nm at 30 h and was kept at about 700 nm during 50-100 h (Fig. 3B) , indicating that the phosphorylation at Thr231-enhanced aggregation of the peptide. Similar data was reported for the phosphorylation at Ser262 [37] , suggesting that phosphorylation commonly enhanced aggregation of the R1 peptide. These experimental results imply that our peptide adequately mimics amyloid-like aggregation-behavior of Tau.
Pin1 does not isomerize the pThr231-Pro232 bond, 2.1% of which is in the cis conformation
In order to estimate the ratio of cis and trans isomers of the pThr231-Pro232 bond, we carried out NMR measurements for another phosphorylated peptide p231-6H3G where R1 domain was deleted to avoid aggregating (Fig. 1A) . The 1 H, 13 C HSQC spectra of the peptide clearly showed that 97.9 AE 0.5% of this peptide took trans conformation at pThr231-Pro232 bond and only 2.1 AE 0.5% took cis conformation (Fig. 4A ), being consistent with the previous report [18] .
Further, we measured PPIase activity of WT Pin1 for p231-6H3G by mixing WT Pin1 to Tau at a ratio of 1 (WT Pin1) to 40 (the peptide). We did not observe any cross-peaks for the cis-trans exchange of p231-6H3G (Fig. 4B) . In addition, the HSQC spectra of the peptide did not change within the error of 0.5% in the presence of Pin1; 97.6 AE 0.1% of this peptide took trans conformation and 2.4 AE 0.1% took cis conformation (Fig. 4A) . Both results suggested that Pin1 did not catalyze the isomerization of the pThr231-Pro232 bond. Next, we tried to detect the chemical exchange of the peptide by 2D EXSY measurements. Figure 4B showed the 2D EXSY spectra of the peptide with 200 ms mixing time in the presence and absence of WT Pin1. This spectrum also did not change after adding WT Pin1. Furthermore, instead of WT Pin1, we repeated these measurements with the isolated PPIase domain, of which PPIase activity was higher than that of WT Pin1 [39] , but obtained the same results (data not shown). We suspected losses in PPIase activity of our Pin1 or nonspecific aggregation of the p231-6H3G peptide because the NMR measurements were performed at high concentrations of Pin1 and the peptide. To check the catalytic activity of Pin1 and the isolated PPIase domain, the same measurements were performed for another peptide Cdc25C, which is a standard substrate for Pin1 [28] . We confirmed that both proteins catalyzed isomerization of Cdc25C peptide under the same condition (Figs 1-2) , indicating that both were active enzymes. To check nonspecific aggregation of the peptide, we measured the spin-spin relaxation time (T 2 ). Crimmins and Kao [40] demonstrated that an unstructured peptide consisting of 68 amino acids adopted monomeric form using size exclusion chromatography, analytical ultracentrifugation, and 1 H NMR relaxation. Compared with 38 ms of the 1 H T 2 relaxation time of the 68-residue peptide [40] , the p231-6H3G peptide consisting of 25 amino acids showed the longer T 2 (about 70 ms) (Fig. S5) . Considering the number and composition of amino acid residues, the difference in T 2 of both peptides strongly suggests the p231-6H3G peptide is monomeric, because T 2 negatively depends on the rotational correlation time of molecule given by the Stokes-Einstein equation. Therefore, we conclude that Pin1 cannot catalyze isomerization of the pThr231-Pro232 bond. Similar observations were reported by Smet et al. [18] and Eichner et al. [19] , in which the PPIase domain of Pin1 interacted with the pThr231-Pro232 bond very weakly but did not catalyze its isomerization, while its WW domain bound to the bond with moderate affinity. In addition, the GST pulldown assay by Innes et al. [41] suggests that the Pro residue immediately following the pSer/pThr-Pro motif, such as pThr231-Pro232-Pro233, drastically reduces the affinity of the PPIase domain.
The WW domain of Pin1 drastically decreases Tau peptide aggregation
To elucidate the function of Pin1 on aggregation of DR1-p231, we monitored propagation of its aggregation in the presence of either of the WW domain or PPIase domain of Pin1 by DLS. It is well known that the WW domain of Pin1 selectively binds to the trans isomer, while the PPIase domain of Pin1 can bind to both isomers but prefers the cis isomer. Therefore, 'cistauosis' behavior of the peptide should be detected in these experiments, that is, aggregation of the cis isomer should decrease by adding the PPIase domain, but not by adding the WW domain. The results, however, were completely opposite. As shown in Fig. 5A ,B, the WW domain dramatically decreased aggregation of the peptide (Z-average-size is about 100 nm at 100 h), while the PPIase domain hardly affected aggregation of the peptide (Z-average-size is about 600 nm at 100 h). To check the mutational effect of the WW domain containing four mutational residues (see Materials and methods), we also investigated propagation of aggregation of DR1-p231 in the presence of fulllength wild-type Pin1 and mutant Pin1. As shown in Fig. 5C , both full-length Pin1s equally decreased aggregation of the peptide more than the WW domain (Z-average-size is < 100 nm at 100 h). This result indicates that the four mutational residues do not contribute to the function of the WW domain in the peptide's aggregation at all.
Even though the PPIase domain does not catalyze the cis isomer, it is thought to interact with it. A high accessibility to pThr231-Pro232 bond is supported by less change in fluorescence of the dansyl group in the vicinity of pThr231-Pro231 bond during the aggregation (Fig. S1) . Therefore, the PPIase domain can probably interact with the bond even during the aggregation. However, the aggregation behavior was similar to that in the absence of the PPIase domain, suggesting the cis isomer hardly contributed to the aggregation of the peptide. On the contrary, in the presence of the WW domain, it is thought that only the trans isomer interacted with the WW domain, and the cis isomer could aggregate as in the case when Pin1 was absent. If the aggregation is caused only by the cis isomer, the amount of aggregation should be similar to that observed in the absence of the WW domain. However, it drastically decreased in the presence of the WW domain. These results indicate that the aggregation observed in the absence of the WW domain was caused mainly by the trans isomer and was inhibited by the WW domain. Consequently, the present experimental results obviously deny the 'cistauosis' hypothesis in which the trans isomer is supposed not to aggregate. In the previous discussion [18, 19] , only NMR played a role to deny the 'cistauosis' because it detected cis and trans isomers directly. NMR, however, is an insufficient technique to deny the hypothesis that only cis isomer aggregates. Although NMR can track reactions ranging milliseconds' time scale at the longest, spontaneous isomerization between cis and trans isomers is much slower, usually from minutes to hours. Therefore, although it can deny the story in which Pin1 prevents aggregation of Tau by its PPIase activity, NMR cannot deny the essence of the hypothesis that only the cis isomer aggregates because it cannot detect the spontaneous slow trans-to-cis isomeric conversion. Such conversion brings about the recovery of equilibrium between cis and trans isomers; thus, only cis Tau may aggregate after trans-to-cis isomeric conversion [12] . In the present study, we introduced novel powerful tools, the The WW domain dramatically decreased aggregation of the peptide (Z-value is about 100 nm at 100 h). (C) Both of full-length wild-type (empty circle) and mutant (filled circle) Pin1s equivalently decreased aggregation of the peptide (those Z-value are < 100 nm at 100 h).
split Pin1 domains, to judge the truth about the hypothesis. Each isomer-specific Pin1 domain interacts with the corresponding isomer of the pThr231-Pro232, and then affects aggregation behavior of the isomer, that is, usually retards its aggregation process if the isomer aggregates. If only the cis isomer aggregates after trans-to-cis isomeric conversion, both of the domains should affect aggregation behavior of the peptide; the PPIase domain would decrease the aggregation more than the WW domain. If either cis or trans isomer aggregates before the isomeric conversion, only one of the domains should affect aggregation behavior of the peptide. In the present study, only the WW domain affected the aggregation behavior, implying that the trans isomer aggregated before the isomeric conversion. Thus, our technique has overcome the obstacles due to the slow equilibrium of isomerization. The present results, however, do not necessarily deny aggregation propensity of the cis isomer. Even if the cis isomer aggregated before the isomeric conversion, the ratio was too low (2.1%) to distinguish its aggregation from that of the trans isomer. Even in the presence of the WW domain, the Z-average-size was still much larger (about 100 nm) than that of the monomeric peptide (< 2 nm). We cannot deny that this aggregation includes the cis isomer. Therefore, the present results suggest that Tau can aggregate in nonisomer-specific manner, but do not inform whether there is a difference in aggregation propensity between the trans and cis isomers.
Did the WW domain inhibit aggregation of the trans isomer by capturing it? According to NMR and ITC experimental results [19] , the dissociation constant between the WW domain and the pThr231-Pro232 bond is about 100-300 lM, suggesting that the WW domain moderately interacts with the peptide but cannot tightly bind to it under the present experimental condition. In addition, actual concentrations of the WW domain and the trans isomer were most 0.5 and 9.8 lM, respectively, that was, the concentration of peptide was about 20 times more than that of WW domain. Therefore, the amount of the WW domain was insufficient to capture all the peptide. Probably the WW domain just touched to the peptide during the incubation. If so, its inhibitory mechanism for aggregation is still unclear.
Apparently, the findings of the present study are inconsistent with the 'cistauosis' hypothesis supported by the previous studies [11, 17] . However, our in-vitro experimental conditions are completely different from their in-vivo conditions; unknown factors in cell, where various biomolecules crowded, might contribute to isomer-specific aggregation of Tau. Therefore, further studies will be necessary to completely elucidate how different in aggregation propensity the trans and cis isomers are and how Pin1 acts to prevent NFT formation in vitro and in vivo.
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